UK to begin prescribing insulin pens to diabetics:
This article was originally published in Clinica
Executive Summary
Reusable insulin pen injectors and their accompanying pen needles will be made available on prescription for the first time in the UK from March 1. The prescribable pens will be Novo Nordisk's Novopen, Becton Dickinson's BD Pen and Owen Mumford's Autopen. Each pen is compatible with all the insulin cartridges currently available in the country. Previously, insulin and syringes were free on prescription but diabetics who used a pen injector had to buy their own needles. There are presently 1.4 million diabetes sufferers in the UK.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.